Dr. Subhash Banerjee, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 247
Licensed in Texas since 2005, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
TX license M1492 (first issued 2005; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor University Medical Center Dallas, TX
- Baylor Scott and White Medical Center Lake Pointe Rowlett, TX
- Baylor Scott & White the Heart Hospital Plano Plano, TX
- Baylor Scott & White Medical Center- Waxahachie Waxahachie, TX
- Baylor Scott & White Heart & Vascular Hospital - Dallas Dallas, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 247
- Services billed
- 1,856
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 98 | 92 |
| Established patient office or other outpatient visit, 30-39 minutes | 92 | 54 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 54 | 34 |
| New patient office or other outpatient visit, 60-74 minutes | 51 | 51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 43 | 43 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 29 | 29 |
| Insertion of needle into vein for collection of blood sample | 28 | 21 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | 20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 20 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Dallas, TX | 128 |
| Ezetimibe Other prescribers in Dallas, TX | 78 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in Dallas, TX | 66 |
| Rosuvastatin Calcium Other prescribers in Dallas, TX | 60 |
| Atorvastatin Calcium Other prescribers in Dallas, TX | 53 |
| Amlodipine Besylate Other prescribers in Dallas, TX | 52 |
| Metoprolol Succinate Other prescribers in Dallas, TX | 51 |
| Losartan Potassium Other prescribers in Dallas, TX | 48 |
| Carvedilol Other prescribers in Dallas, TX | 42 |
| Furosemide Other prescribers in Dallas, TX | 37 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 52 payments worth $14,974 in total to this clinician.
| Kaneka Medical America LLC | $5,049 |
|---|---|
| Biotronik Inc. | $5,009 |
| Terumo Medical Corporation | $1,696 |
| Teleflex LLC | $910 |
| Medtronic, Inc. | $519 |
| Edwards Lifesciences Corporation | $471 |
| Amgen Inc. | $397 |
| Spectrawave, Inc | $297 |
| Compensation for services other than consulting (speaking, faculty) | $5,049 |
|---|---|
| Speaking at a medical education program | $4,880 |
| Food and Beverage | $3,395 |
| Consulting Fee | $1,650 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Kaneka Medical America LLC Jul 7, 2025 | Compensation for services other than consulting (speaking, faculty) Apheresis Machine · Nephrology | $5,049 |
| Biotronik Inc. May 1, 2025 | Speaking at a medical education programCompany’s description131874 | $4,880 |
| Terumo Medical Corporation Jan 22, 2025 | Consulting Fee METACROSS OTW · LESION THERAPY | $1,200 |
| Terumo Medical Corporation Mar 26, 2025 | Consulting Fee METACROSS OTW · LESION THERAPY | $450 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 5 companies. The companies reported $159,761 in research payments for these studies, mostly to the institutions running them.
- XLCAD CLINICAL REGISTRY
Teleflex LLC - Evaluation of Cardiorenal and Limb Outcomes
GE Healthcare - Predicting 10-year risk of cardiovascular events in Baylor Scott & White Cardiology Patients with Established Cardiovascular Disease
Esperion Therapeutics, Inc. - Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
Philips North America LLC · Recruiting · NCT07353905 - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Abbott Laboratories · Active, not recruiting · NCT03108456
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.